NEW YORK, Oct. 25 (GenomeWeb News) - Shares in Genaissance Pharmaceuticals slid more than 7 percent this afternoon as investors continued to punish the company for saying it planned to miss year-end revenue expectations.
...and receive Daily News bulletins.
Already have an account?Login Now.
23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.
A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.
